Health Care

Launch Prices for New Drugs Have Doubled Since 2005

Jun 08, 2021

Analysis suggests Medicare Part B reimbursement encourages high drug prices

Launch prices for new drugs have doubled since 2005, according to research from Duke University’s Fuqua School of Business. The data links the high prices to a 2005 change in the way Medicare reimburses doctors and other providers for Part B medications, which are drugs and treatments delivered in outpatient settings, said David... read more

Making Value-Based Health Care Valuable
Using A Game Theory Mindset to Help Vaccinate the World
Why You Probably Won’t Get a COVID-19 Vaccine Anytime Soon
Ubel: Antibody Tests Could Offer A False Sense of Security
McClellan: Economic Outlook Could Become Clearer in Weeks
As Large Chains Grow to Dominate Dialysis, Patient Outcomes Decline
How the Medicare Reimbursement System Drives Up Drug Prices
Drug Review Incentive Pivotal to New Neglected Tropical Disease Treatment
When the U.S. Spends More on Fighting a Disease, the Rest of the World Spends Less
A Proposal to Generate Insecticides that Could Save Millions of Lives
Health Reform: Past, Present and Future
How Medicare Could Save Millions
The Problem with Copay Coupons
Health Care: China’s Innovation Hotbed
Physicians Describe Available Treatments More Positively, Research Finds
New Research Urges Caution in Expansion of Drug Development Incentive Program
Using Price to Avoid Vaccine Shortages
A One Minute Conversation Could Save on Medical Costs
Secretary of Veterans Affairs Discusses Impactful Leadership
New FDA Nutrition Labels Could Feed Unhealthy Eating
New Research Predicts Market Share for Drug Makers
How to Keep Antibiotics Effective
Research Shows Health Exchange Website Design Influences Choice
Drug Review Incentive Proposed by Fuqua Faculty Spurs Non-Profit Investment
Researchers Suggest Fixing Affordable Care Act's Calorie Range Requirement
New Research Shows 'Death Panel' Myth Hard to Correct
Doctors Recommend Different Treatments for Patients than They'd Choose for Themselves
European Union Could Create Incentive for New Drug Treatments

FUQUA INSIGHTS ARCHIVE FUQUA INSIGHTS Home

Browse By

Daytime MBA

Health Care

Launch Prices for New Drugs Have Doubled Since 2005